NASDAQ
Clarus Therapeutics Holdings, Inc. (CRXTQ) has a free cash flow growth of -1.35% as of Friday, May 29, 2026. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.